Diagnostic value of skeletal AP and PSA with respect to skeletal scintigram in patients with prostatic disease

Anticancer Research

Volumn 17, Issue 4 B, 1997, Pages 3035-3036

  Oremek, G M ^a   Kramer, W ^a   Seiffert, U B ^a   Jonas, D ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Bone metastases; Prostatic cancer; PSA; SAP; Skeletal scintigram

Indexed keywords

ALKALINE PHOSPHATASE; PROSTATE SPECIFIC ANTIGEN;

BLOOD LEVEL; BONE METASTASIS; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SCINTIGRAPHY;

ALKALINE PHOSPHATASE; BONE AND BONES; BONE NEOPLASMS; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 0030769788     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Hill CS, Wolfert RL: The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta 186: 315-320, 1989.
2. Delmas PD: Biochemical markers of bone turnover. J Bone Min Res, 8: 549-555, 1993.
3. Carnero P, Dermas PD: Assessment of the serum levels of bone alkaline phosphatase with new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77: 1046-1053, 1993.
4. Yerna MJ et al: Tandem®-R-Ostase™ Ein immunoradiometrischer Assay (IRMA) zur quantitativen Bestimmung der Skelett alkalischen Phosphatase Lab med 18: 78-79, 1994.
5. Van Straalen JP: Bone alkaline phosphatase as indicator of bone formation Clin Chim Acta 207: 27-30, 1991.
6. Semjonow A, Adomeit HJ, Rathert P: Skeletal alkaline phosphatase as serum marker for bone metastases In: R.K Lapdor: Current Tumor Diagnosi-Applications, Clinical Relevance, Research, trend, Cancer of the Lung, State and Trend in Diagnosis and Therapy 1994 p 334-336, 1994.
7. Cooper EH, Forbes MA, Darte C: Der Einsath der Tandem®-R-Ostase™ Assays zur Untersuchung der Skelettalkalischen-Phosphatase beim metastasierenden Brust- und Prostatakrebs Lab Med 18: 80-81, 1994.